|
TMEM50B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62825308791525E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.05102601569251E-12 |
| Normal-vs-Stage2 |
6.8442000000779E-07 |
| Normal-vs-Stage3 |
3.82429976575338E-10 |
| Normal-vs-Stage4 |
9.69229999592258E-08 |
| Stage1-vs-Stage2 |
9.318800E-01 |
| Stage1-vs-Stage3 |
1.625150E-01 |
| Stage1-vs-Stage4 |
1.185550E-01 |
| Stage2-vs-Stage3 |
2.743200E-01 |
| Stage2-vs-Stage4 |
1.451560E-01 |
| Stage3-vs-Stage4 |
5.284800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68698388591793E-12 |
| Normal-vs-AfricanAmerican |
5.76749759062523E-12 |
| Normal-vs-Asian |
1.79997999999459E-05 |
| Caucasian-vs-AfricanAmerican |
9.794800E-01 |
| Caucasian-vs-Asian |
2.163200E-01 |
| AfricanAmerican-vs-Asian |
1.468160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62558855265615E-12 |
| Normal-vs-Female |
3.29950000654833E-09 |
| Male-vs-Female |
9.824100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.18112244616032E-12 |
| Normal-vs-Extreme_Weight |
1.10820241872034E-11 |
| Normal-vs-Obese |
1.8824000025397E-08 |
| Normal-vs-Extreme_Obese |
1.09979999995957E-06 |
| Normal_Weight-vs-Extreme_Weight |
6.641800E-01 |
| Normal_Weight-vs-Obese |
2.275800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.982600E-01 |
| Extreme_Weight-vs-Obese |
3.942800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.063400E-01 |
| Obese-vs-Extreme_Obese |
2.486800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.17469964048212E-10 |
| Normal-vs-Age(41-60Yrs) |
1.21369581052022E-11 |
| Normal-vs-Age(61-80Yrs) |
6.26165785888588E-13 |
| Normal-vs-Age(81-100Yrs) |
3.37929999982833E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.255900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.394800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.418400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.473400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.666600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.435000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.67780242424465E-11 |
| Normal-VS-Type2 PRCC |
1.22124532708767E-15 |
| Normal-VS-KIRP CIMP |
7.75099999739126E-08 |
| Normal-VS-Unclassified PRCC |
1.22730003937477E-09 |
| Type1 PRCC-VS-Type2 PRCC |
8.027800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.613700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.841580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.900400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.288000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.296790E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56541446472147E-14 |
| Normal-vs-N1 |
5.40911759827623E-12 |
| Normal-vs-N2 |
4.197700E-04 |
| N0-vs-N1 |
7.634400E-01 |
| N0-vs-N2 |
7.173800E-01 |
| N1-vs-N2 |
7.904600E-01 |
|
|
